Pearson A R, Tanner V, Keightley S J, Casswell A G
Sussex Eye Hospital, Brighton, UK.
Eye (Lond). 1998;12 ( Pt 1):64-8. doi: 10.1038/eye.1998.12.
Although laser panretinal photocoagulation (PRP) for proliferative diabetic retinopathy is known to cause peripheral field constriction, the risks of failing the UK driving field test following treatment are currently unclear as the small number of previous studies have conflicting results. Following PRP using only argon laser with a 500 microns spot size, both uniocular and binocular Esterman visual fields from 60 diabetic patients were assessed by the Chairman of the Visual Standards Sub-Committee of the Royal College of Ophthalmologists. Forty-two per cent of uniocular fields from treated eyes failed. Twelve per cent of binocular fields from those having bilateral PRP failed. Type II diabetes was associated with a significant increase in the risk of failure. Although there is a high risk of failure in any given treated eye, 88% of diabetics will pass a binocular field test, even if both eyes are treated.
虽然已知增殖性糖尿病视网膜病变的激光全视网膜光凝术(PRP)会导致周边视野缩窄,但由于此前的少量研究结果相互矛盾,目前尚不清楚治疗后未能通过英国驾驶视野测试的风险。在仅使用光斑大小为500微米的氩激光进行PRP治疗后,皇家眼科医学院视觉标准小组委员会主席对60名糖尿病患者的单眼和双眼Esterman视野进行了评估。治疗眼的单眼视野有42%未通过。接受双侧PRP治疗者的双眼视野有12%未通过。2型糖尿病与失败风险的显著增加相关。尽管任何一只接受治疗的眼睛都有很高的失败风险,但88%的糖尿病患者即使双眼都接受了治疗,仍能通过双眼视野测试。